$175.79
À la fermeture: Sep 11 EDT
$175.94
0.150.09%
Pré-commercialisation: 9:04 AM EDT
Comments
Loading...
Orientation et prévision
Johnson & Johnson publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/16/2025 | JNJ | Johnson & Johnson | FY | 2025 | $10.80 | $10.90 | $10.62 | $93.20B | $93.60B | $91.33B | |
04/15/2025 | JNJ | Johnson & Johnson | FY | 2025 | $10.50 | $10.70 | $10.50 | $91.00B | $91.80B | $90.29B | |
01/22/2025 | JNJ | Johnson & Johnson | FY | 2025 | $10.50 | $10.70 | $10.60 | $89.20B | $90.00B | $91.09B | |
10/15/2024 | JNJ | Johnson & Johnson | FY | 2024 | $9.88 | $9.98 | $9.84 | $88.40B | $88.80B | $88.51B | |
07/17/2024 | JNJ | Johnson & Johnson | FY | 2024 | $9.97 | $10.07 | $10.01 | $88.00B | $88.40B | $88.74B | |
04/16/2024 | JNJ | Johnson & Johnson | FY | 2024 | $10.57 | $10.72 | $10.65 | $88.00B | $88.40B | $88.43B | |
01/23/2024 | JNJ | Johnson & Johnson | FY | 2024 | $10.55 | $10.75 | $10.67 | $87.80B | $88.60B | $87.97B | |
12/05/2023 | JNJ | Johnson & Johnson | FY | 2024 | $10.55 | $10.75 | $10.78 | — | — | — | |
11/30/2023 | JNJ | Johnson & Johnson | FY | 2023 | $9.90 | $9.96 | $9.16 | — | — | — | |
10/17/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.07 | $10.13 | $10.03 | $83.60B | $84.00B | $84.53B | |
08/30/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.00 | $10.10 | $10.75 | $83.20B | $84.00B | $100.23B | |
07/20/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.70 | $10.80 | $10.65 | $98.80B | $99.80B | $98.96B | |
04/18/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.60 | $10.70 | $10.51 | $97.90B | $98.90B | $97.71B | |
01/24/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.45 | $10.65 | $10.33 | $96.90B | $97.90B | $97.84B | |
10/18/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.02 | $10.07 | $10.03 | $93.00B | $93.50B | $94.85B | |
09/14/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.65 | $10.75 | $10.07 | — | — | — | |
07/19/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.00 | $10.10 | $10.27 | $93.30B | $94.30B | $96.04B | |
04/19/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.15 | $10.35 | $10.52 | $94.80B | $95.80B | $99.48B | |
01/25/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.40 | $10.60 | $10.37 | $98.90B | $100.40B | $97.88B | |
10/19/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.77 | $9.82 | $9.66 | $94.10B | $94.60B | $94.30B | |
07/21/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.60 | $9.70 | $9.52 | $93.80B | $94.60B | $91.30B | |
04/20/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.42 | $9.57 | $9.50 | $90.60B | $91.60B | $92.23B | |
01/26/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.40 | $9.60 | $8.99 | $90.50B | $91.70B | $89.00B |
FAQ
Quelles sont les dernières directives pour Johnson & Johnson (JNJ) ?
Les dernières prévisions pour Johnson & Johnson (JNJ) ont été communiquées le juillet 16, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $10.80 à $10.90, par rapport à un BPA estimé de $10.62. De plus, Johnson & Johnson a prévu un chiffre d'affaires entre $93.20B et $93.60B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.